214 related articles for article (PubMed ID: 19397856)
1. Evaluation of [64Cu]Cu-DOTA and [64Cu]Cu-CB-TE2A chelates for targeted positron emission tomography with an alphavbeta6-specific peptide.
Hausner SH; Kukis DL; Gagnon MK; Stanecki CE; Ferdani R; Marshall JF; Anderson CJ; Sutcliffe JL
Mol Imaging; 2009; 8(2):111-21. PubMed ID: 19397856
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner SH; Bauer N; Hu LY; Knight LM; Sutcliffe JL
J Nucl Med; 2015 May; 56(5):784-90. PubMed ID: 25814519
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Copper-64-Labeled α
Ganguly T; Bauer N; Davis RA; Hausner SH; Tang SY; Sutcliffe JL
Mol Pharm; 2021 Dec; 18(12):4437-4447. PubMed ID: 34783573
[TBL] [Abstract][Full Text] [Related]
4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64.
Jensen AI; Binderup T; Kumar EK P; Kjær A; Rasmussen PH; Andresen TL
Biomacromolecules; 2014 May; 15(5):1625-33. PubMed ID: 24645913
[TBL] [Abstract][Full Text] [Related]
6. Targeted in vivo imaging of integrin alphavbeta6 with an improved radiotracer and its relevance in a pancreatic tumor model.
Hausner SH; Abbey CK; Bold RJ; Gagnon MK; Marik J; Marshall JF; Stanecki CE; Sutcliffe JL
Cancer Res; 2009 Jul; 69(14):5843-50. PubMed ID: 19549907
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.
Kumar SR; Gallazzi FA; Ferdani R; Anderson CJ; Quinn TP; Deutscher SL
Cancer Biother Radiopharm; 2010 Dec; 25(6):693-703. PubMed ID: 21204764
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo evaluation of the effects of aluminum [¹⁸F]fluoride radiolabeling on an integrin αvβ₆-specific peptide.
Hausner SH; Bauer N; Sutcliffe JL
Nucl Med Biol; 2014 Jan; 41(1):43-50. PubMed ID: 24267053
[TBL] [Abstract][Full Text] [Related]
9. Characterization and evaluation of (64)Cu-labeled A20FMDV2 conjugates for imaging the integrin αvβ 6.
Hu LY; Bauer N; Knight LM; Li Z; Liu S; Anderson CJ; Conti PS; Sutcliffe JL
Mol Imaging Biol; 2014 Aug; 16(4):567-77. PubMed ID: 24448825
[TBL] [Abstract][Full Text] [Related]
10. The Effects of an Albumin Binding Moiety on the Targeting and Pharmacokinetics of an Integrin α
Hausner SH; Bauer N; Davis RA; Ganguly T; Tang SYC; Sutcliffe JL
Mol Imaging Biol; 2020 Dec; 22(6):1543-1552. PubMed ID: 32383076
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.
Cai W; Wu Y; Chen K; Cao Q; Tice DA; Chen X
Cancer Res; 2006 Oct; 66(19):9673-81. PubMed ID: 17018625
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an integrin αvβ6-specific peptide labeled with [18F]fluorine by copper-free, strain-promoted click chemistry.
Hausner SH; Carpenter RD; Bauer N; Sutcliffe JL
Nucl Med Biol; 2013 Feb; 40(2):233-9. PubMed ID: 23265667
[TBL] [Abstract][Full Text] [Related]
13. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
Hausner SH; DiCara D; Marik J; Marshall JF; Sutcliffe JL
Cancer Res; 2007 Aug; 67(16):7833-40. PubMed ID: 17699789
[TBL] [Abstract][Full Text] [Related]
14. (64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.
Wei L; Ye Y; Wadas TJ; Lewis JS; Welch MJ; Achilefu S; Anderson CJ
Nucl Med Biol; 2009 Apr; 36(3):277-85. PubMed ID: 19324273
[TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
[TBL] [Abstract][Full Text] [Related]
16. ImmunoPET Imaging of α
White JB; Hu LY; Boucher DL; Sutcliffe JL
Mol Imaging Biol; 2018 Feb; 20(1):103-113. PubMed ID: 28653240
[TBL] [Abstract][Full Text] [Related]
17. (64)Cu-labeled tetrameric and octameric RGD peptides for small-animal PET of tumor alpha(v)beta(3) integrin expression.
Li ZB; Cai W; Cao Q; Chen K; Wu Z; He L; Chen X
J Nucl Med; 2007 Jul; 48(7):1162-71. PubMed ID: 17574975
[TBL] [Abstract][Full Text] [Related]
18. Dual-function probe for PET and near-infrared fluorescence imaging of tumor vasculature.
Cai W; Chen K; Li ZB; Gambhir SS; Chen X
J Nucl Med; 2007 Nov; 48(11):1862-70. PubMed ID: 17942800
[TBL] [Abstract][Full Text] [Related]
19. Improved PET imaging of uPAR expression using new (64)Cu-labeled cross-bridged peptide ligands: comparative in vitro and in vivo studies.
Persson M; Hosseini M; Madsen J; Jørgensen TJ; Jensen KJ; Kjaer A; Ploug M
Theranostics; 2013; 3(9):618-32. PubMed ID: 24052804
[TBL] [Abstract][Full Text] [Related]
20. Preparation and biological evaluation of copper-64-labeled tyr3-octreotate using a cross-bridged macrocyclic chelator.
Sprague JE; Peng Y; Sun X; Weisman GR; Wong EH; Achilefu S; Anderson CJ
Clin Cancer Res; 2004 Dec; 10(24):8674-82. PubMed ID: 15623652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
